Fundamental Analysis Report – TEVA PHARMACEUTICAL INDUSTRIES LTD. (TEVA)

In-depth Analysis Report – Teva Pharmaceutical Industries Ltd. (TASE: TEVA)
 A professional, data-driven report on Teva, the largest pharmaceutical manufacturer in Israel and one of the world's leaders in the generic and branded market. The document includes a full analysis of the second quarter reports for 2025, a full update of revenue, profit and cash flow forecasts, a breakdown of the performance of key products (AUSTEDO, AJOVY, UZEDY), and a review of the progress of the Pivot to Growth strategy.
 Full operational data: Revenue, EBITDA, ROE, Cash Flow, Multiples
 Segmentation by areas of activity – generics, specialty drugs, API division
 Analysis of risks, opportunities, legal proceedings and debt management
 Especially recommended for investors looking for depth, clarity, and a realistic understanding of the value of Teva stock.